The next difficult task in combating the COVID-19 pandemic will be to effectively distribute the vaccine and convince sufficient numbers of individuals to be vaccinated in order for herd immunity to be successful.
Study authors provided a systemic analysis of to identify key characteristics of extensive and advanced COVID-19.
The Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology provided new clinical practice guidelines for Lyme disease prevention, diagnosis, and treatment.
SARS-CoV-2’s association with encephalitis was assessed by authors, taking varying clinical presentations, responses to treatment, and outcomes into account.
People with HIV, particularly patients in sub-Saharan Africa and Latin America, have a high burden of HIV-associated neurocognitive disorder.
A third of patients presented with an altered mental state, including 9 patients with unspecified encephalopathy, 7 with encephalitis, and 23 fulfilling the clinical definition for psychiatric diagnoses.
A randomized controlled trial comprising infants revealed a reduced schedule of a 4-component capsular group B meningococcal vaccine (4CMenB) was immunogenic and established immunologic memory after booster vaccination.
A brief communication provides information about the associations between, and the considerations for, COVID-19 and epilepsy.
A patient with a history of pulmonary paracoccidioidomycosis presented with relapsed disease in the central nervous system four years after initial treatment.
Acute respiratory distress syndrome (ARDS) due to COVID-19 is associated with neurologic features, including encephalopathy, agitation, and confusion
